Literature DB >> 16678140

Low penetrance, subclinical congenital LQTS: concealed LQTS or silent LQTS?

Andras Varró, Julius Gy Papp.   

Abstract

Mesh:

Substances:

Year:  2006        PMID: 16678140     DOI: 10.1016/j.cardiores.2006.04.006

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


× No keyword cloud information.
  6 in total

1.  Arrhythmia formation in subclinical ("silent") long QT syndrome requires multiple insults: quantitative mechanistic study using the KCNQ1 mutation Q357R as example.

Authors:  Thomas O'Hara; Yoram Rudy
Journal:  Heart Rhythm       Date:  2011-09-25       Impact factor: 6.343

Review 2.  Cardiac ventricular repolarization reserve: a principle for understanding drug-related proarrhythmic risk.

Authors:  András Varró; István Baczkó
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

Review 3.  Minimizing repolarization-related proarrhythmic risk in drug development and clinical practice.

Authors:  Attila S Farkas; Stanley Nattel
Journal:  Drugs       Date:  2010-03-26       Impact factor: 9.546

4.  Combined pharmacological block of I(Kr) and I(Ks) increases short-term QT interval variability and provokes torsades de pointes.

Authors:  C Lengyel; A Varró; K Tábori; J G Papp; I Baczkó
Journal:  Br J Pharmacol       Date:  2007-05-29       Impact factor: 8.739

5.  Heat shock protein 70 gene polymorphisms' influence on the electrophysiology of long QT syndrome.

Authors:  Altaf Ali; Sameera F Qureshi; Veronica Medikare; Ananthapur Venkateshwari; Narsimhan Calambur; Hygriv Rao; M P Jayakrishnan; Jayaprakash Shenthar; Kumarasamy Thangaraj; Pratibha Nallari
Journal:  J Interv Card Electrophysiol       Date:  2015-12-16       Impact factor: 1.900

6.  Increased short-term variability of the QT interval in professional soccer players: possible implications for arrhythmia prediction.

Authors:  Csaba Lengyel; Andrea Orosz; Péter Hegyi; Zsolt Komka; Anna Udvardy; Edit Bosnyák; Emese Trájer; Gábor Pavlik; Miklós Tóth; Tibor Wittmann; Julius Gy Papp; András Varró; István Baczkó
Journal:  PLoS One       Date:  2011-04-15       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.